Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism

2004 • 1,770 citations

Inhaled Iloprost for Severe Pulmonary Hypertension

2002 • 1,760 citations

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

2001 • 1,521 citations

Chronic thromboembolic pulmonary hypertension.

2006 • 1,170 citations

Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension

2000 • 1,129 citations

Chronic thromboembolic pulmonary hypertension

2018 • 885 citations

Longterm Follow-up of Patients with Pulmonary Thromboembolism

1982 • 800 citations

Pulmonary endarterectomy: experience and lessons learned in 1,500 cases

2003 • 756 citations

Pulmonary Vascular Lesions Occurring in Patients With Chronic Major Vessel Thromboembolic Pulmonary Hypertension

1993 • 611 citations

Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary Hypertension

2006 • 400 citations

Chronic thromboembolic pulmonary hypertension

2004 • 396 citations

Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension

2008 • 396 citations

Long-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension

2008 • 264 citations

Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension

2004 • 260 citations

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions

2006 • 258 citations

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era

2005 • 242 citations

Interventional and surgical modalities of treatment for pulmonary arterial hypertension

2004 • 240 citations

Selective Upregulation of Endothelin B Receptor Gene Expression in Severe Pulmonary Hypertension

2002 • 224 citations

Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension

2005 • 202 citations

Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension

2007 • 181 citations

The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study

2006 • 155 citations

Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension

2005 • 152 citations

Reverse right ventricular remodeling after pulmonary endarterectomy

2006 • 115 citations

Assessment of Operability in Chronic Thromboembolic Pulmonary Hypertension

2006 • 102 citations

Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

2007 • 100 citations

Long-Term Recovery of Exercise Ability After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension

2006 • 94 citations

Techniques and Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension

2006 • 91 citations

Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy

2003 • 74 citations

Chronic thromboembolic pulmonary hypertension

2004 • 65 citations

PULMONARY VASCULAR REMODELING DISTAL TO PULMONARY ARTERY LIGATION IS ACCOMPANIED BY UPREGULATION OF ENDOTHELIN RECEPTORS AND NITRIC OXIDE SYNTHASE

2000 • 63 citations

Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension

2007 • 62 citations

Long-Term Bosentan in Chronic Thromboembolic Pulmonary Hypertension

2006 • 58 citations

Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension

2001 • 55 citations